In our study, we were interested in the role of the immunosuppressive cytokines TGF-β1 and IL-10 in RA and, in particular, the influence of the genetic terrain on their levels as a prerequisite for RA and disease activity clinical features. This evidence concerns the gene TGFB1 and rheumatoid arthritis.